Suppr超能文献

利用富血小板血浆技术实现干细胞的安全高效体外扩增。

Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology.

作者信息

Anitua Eduardo, Prado Roberto, Orive Gorka

机构信息

Eduardo Anitua. Instituto Eduardo Anitua; c/Jose Maria Cagigal 19, 01007 Vitoria, Spain.

出版信息

Ther Deliv. 2013 Sep;4(9):1163-77. doi: 10.4155/tde.13.68.

Abstract

The goal of this Review is to provide an overview of the cell culture media supplements used in the ex vivo expansion of stem cells intended for cell therapy. Currently, the gold standard is the culture supplemented with fetal bovine serum, however, their use in cell therapy raises many concerns. The alternatives to its use are presented, ranging from the use of human serum to platelet-rich plasma (PRP), to serum-free media or extracellular matrix components. Finally, various growth factors present in PRP are described, which make it a safe and effective stem cell expansion supplement. These growth factors could be responsible for their efficiency, as they increase both stem cell proliferation and survival. The different PRP formulations are also discussed, as well as the need for protocol standardization.

摘要

本综述的目的是概述用于细胞治疗的干细胞体外扩增的细胞培养基补充剂。目前,金标准是添加胎牛血清的培养基,然而,其在细胞治疗中的使用引发了许多担忧。介绍了其替代物,从人血清到富血小板血浆(PRP),再到无血清培养基或细胞外基质成分。最后,描述了PRP中存在的各种生长因子,这些生长因子使其成为一种安全有效的干细胞扩增补充剂。这些生长因子可能是其有效性的原因,因为它们既能增加干细胞的增殖又能提高其存活率。还讨论了不同的PRP配方以及方案标准化的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验